Biogen at WMS 2024: Stephanie Fradette from Biogen in an Illuminating Dialogue Exchange with PharmaShots
Shots: Biogen recently shared findings from the P-II/III DEVOTE study,...
Shots: Biogen recently shared findings from the P-II/III DEVOTE study,...
Shots: Misfolded TTR can lead to chronic conditions like ATTRv-PN or A...
Shots: Johnson & Johnson’s (J&J) Tremfya recently received its third...
Shots: At ESC 2024, AstraZeneca presented insights from the real-world...
Shots: At the European Academy of Dermatology and Venereology (EADV) 2...
Shots: GAIN JPAC is an emerging platform where leaders in aesthetics c...
Incisive News in 3 Shots.
Modal body text goes here.